Literature DB >> 18484794

Aripiprazole in adolescents with schizophrenia: profile report.

Mark Sanford1, Gillian M Keating.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18484794     DOI： 10.2165/00023210-200822060-00006

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  7 in total

Review 1.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Children with schizophrenia: clinical picture and pharmacological treatment.

Authors:  Gabriele Masi; Maria Mucci; Cinzia Pari
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Predictors of the early 5-year course of schizophrenia: a path analysis.

Authors:  Marie E Lenior; Peter M A J Dingemans; Aart H Schene; Don H Linszen
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

4.  AACAP official action. Summary of the practice parameters for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-12       Impact factor: 8.829

Review 5.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Teenage psychoses--epidemiology, classification and reduced optimality in the pre-, peri- and neonatal periods.

Authors:  C Gillberg; J Wahlström; A Forsman; L Hellgren; I C Gillberg
Journal:  J Child Psychol Psychiatry       Date:  1986-01       Impact factor: 8.982

Review 7.  Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.

Authors:  Sanjiv Kumra; Joel V Oberstar; Linmarie Sikich; Robert L Findling; Jon M McClellan; Sophia Vinogradov; S Charles Schulz
Journal:  Schizophr Bull       Date:  2007-10-08       Impact factor: 9.306
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.